NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,096 filers reported holding NOVARTIS A G in Q2 2019. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $3,446,000 | -3.6% | 37,744 | +1.5% | 1.38% | -14.2% |
Q1 2019 | $3,576,000 | -88.7% | 37,193 | +0.6% | 1.60% | +6.4% |
Q4 2018 | $31,732,000 | +885.8% | 36,980 | -2.7% | 1.51% | +12.1% |
Q3 2018 | $3,219,000 | +12.8% | 37,995 | +0.6% | 1.35% | +7.9% |
Q2 2018 | $2,854,000 | -2.6% | 37,783 | +4.2% | 1.25% | +0.1% |
Q1 2018 | $2,931,000 | -2.1% | 36,250 | +1.7% | 1.25% | +2.0% |
Q4 2017 | $2,993,000 | -0.7% | 35,644 | +1.5% | 1.22% | -3.3% |
Q3 2017 | $3,014,000 | +3.3% | 35,103 | +0.4% | 1.26% | -2.5% |
Q2 2017 | $2,917,000 | +6.3% | 34,946 | -5.4% | 1.30% | +5.0% |
Q1 2017 | $2,744,000 | +1.4% | 36,952 | -0.5% | 1.24% | -2.0% |
Q4 2016 | $2,707,000 | -8.5% | 37,150 | -0.9% | 1.26% | -8.4% |
Q3 2016 | $2,960,000 | -4.1% | 37,480 | +0.2% | 1.38% | -7.2% |
Q2 2016 | $3,086,000 | +16.0% | 37,404 | +1.9% | 1.48% | +0.3% |
Q1 2016 | $2,660,000 | – | 36,721 | – | 1.48% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |